PureTech Health PLC - Boston-based biotechnology company - Says its founded entity, Akili, announced clinical trial for video game-based therapy, EndeavorRx, showed improvement in attention and quality of life for people with attention deficit hyperactivity disorder. Notes attention improved in more than 80% of adults with ADHD, while over a third of participants "no longer exhibited an attention deficit following treatment."
EndeavorRv is the only US Food & Drug Administration authorised treatment delivered through video game experience. It is meant to improve attention function in children with ADHD. Data from trial on adults will be submitted to the FDA later this year.
Current stock price: 218.50 pence, trading flat on Thursday
12-month change: up 30%
By Sabrina Penty; Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
PureTech (PRTC)